MedMira Inc. (TSXV:MIR)
0.0850
-0.0100 (-10.53%)
May 2, 2025, 12:02 PM EDT
MedMira Revenue
MedMira had revenue of 69.00K CAD in the quarter ending January 31, 2025, a decrease of -53.60%. This brings the company's revenue in the last twelve months to 276.73K, down -32.14% year-over-year. In the fiscal year ending July 31, 2024, MedMira had annual revenue of 412.57K, down -4.61%.
Revenue (ttm)
276.73K
Revenue Growth
-32.14%
P/S Ratio
215.54
Revenue / Employee
5.32K
Employees
52
Market Cap
59.65M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 412.57K | -19.96K | -4.61% |
Jul 31, 2023 | 432.53K | -519.60K | -54.57% |
Jul 31, 2022 | 952.13K | -1.19M | -55.60% |
Jul 31, 2021 | 2.14M | 1.23M | 133.33% |
Jul 31, 2020 | 919.07K | 391.63K | 74.25% |
Jul 31, 2019 | Pro | Pro | Pro |
Jul 31, 2018 | Pro | Pro | Pro |
Jul 31, 2017 | Pro | Pro | Pro |
Jul 31, 2016 | Pro | Pro | Pro |
Jul 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.55B |
Sienna Senior Living | 893.16M |
Trulieve Cannabis | 1.71B |
Extendicare | 1.47B |
Curaleaf Holdings | 1.93B |
WELL Health Technologies | 919.69M |
Cronos Group | 169.23M |
MedMira News
- 16 days ago - MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense - Accesswire
- 4 weeks ago - Medmira reports Q2 results - Seeking Alpha
- 4 weeks ago - MedMira Reports Second Quarter Results FY2025 - Accesswire
- 2 months ago - MedMira Announces Partnership with MediGroup Physician Services in the United States - Accesswire
- 2 months ago - MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada - Accesswire
- 3 months ago - MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications - Accesswire
- 3 months ago - MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications - Accesswire
- 3 months ago - MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use - Accesswire